Entries from India Chemicals Blog tagged with 'DowPharma'

Pharma still keen on M&As

The Indian pharmaceutical sector is keeping the M&A fire burning with six deals concluded last month, up from eight in the January-March period. The list includes Jubilant Organosys' $255m acquisition of US-based DRAXIS Health and the $218m buyout of Dabur...